发明名称 Pyrazole compounds useful as protein kinase inhibitors
摘要 Pyrazole compounds of formula (IV) are described. The compounds are useful as protein kinase inhibitors, especially as inhibitors of Aurora-2 and GSK-3, and for treating diseases such as cancer, diabetes, AlzheimersÆs disease, HuntingtonÆs disease, ParkinsonÆs disease, AIDS-associated dementia, amyotrophic lateral sclerosis, multiple scerosis, schizophrenia, cardiomycete hypertrophy, reperfusion/ischemia and baldness. The compounds are also useful in the manufacture of a medicament for enhancing glycogen synthesis or lowering blood levels of glucose, for inhibiting the production of hyperphosphorylated Tau protein or for inhibiting the phosphorylation of beta-catenin.
申请公布号 NZ526473(A) 申请公布日期 2005.06.24
申请号 NZ20010526473 申请日期 2001.12.19
申请人 VERTEX PHARMACEUTICALS INCORPORATED 发明人 BEBBINGTON, DAVID;CHARRIER, JEAN-DAMIEN
分类号 C12N9/99;A61K;A61K31/435;A61K31/4439;A61K31/444;A61K31/4709;A61K31/4725;A61K31/496;A61K31/501;A61K31/506;A61K31/513;A61K31/517;A61K31/519;A61K31/53;A61K31/5377;A61K31/541;A61K31/55;A61K45/00;A61P;A61P1/00;A61P3/08;A61P3/10;A61P3/14;A61P5/00;A61P5/18;A61P9/00;A61P9/04;A61P9/08;A61P9/10;A61P11/06;A61P13/12;A61P15/00;A61P17/06;A61P17/14;A61P19/02;A61P19/08;A61P19/10;A61P21/00;A61P21/02;A61P21/04;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P25/18;A61P25/28;A61P29/00;A61P31/12;A61P31/18;A61P31/20;A61P31/22;A61P35/00;A61P35/02;A61P35/04;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D;C07D401/12;C07D401/14;C07D403/12;C07D403/14;C07D405/14;C07D407/14;C07D409/14;C07D413/14;C07D417/14;C07D471/04;C07D473/16;C07D487/04;C07D491/04;C07D493/04;C07D495/04;C07D498/04;C07D513/04;C07D521/00;(IPC1-7):C07D401/12;A61K31/415;A61K31/442;A61K31/470 主分类号 C12N9/99
代理机构 代理人
主权项
地址